What's breaking now, across thousands of outlets.
Sanofi is dropping an experimental drug targeting a pathway that many analysts see as a potential pillar of the next generation of immunology medicine. The company will no longer pursue the program known as SAR448272 ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), together with international collaborators, have uncovered previously unknown mechanisms that allow blood…
Aggressive brain tumors follow predictable rules, not chaotic randomness, according to new research. This discovery could lead to new, much-needed ways to treat glioblastoma tumors in the future.
[Vanguard] Sunu Assurances Nigeria PLC and SUNU Health Nigeria Limited, in collaboration with H2O Wellness Foundation, has sensitised over 60 women including 40 radio presenters, on breast cancer…
Hanan Balkhy, Saudi Arabia’s candidate for WHO Director General, is especially concerned about antibiotic resistance, the effects of climate change on health, and healthcare in conflict zones.
The drug’s third-quarter sales numbers came in well above consensus estimates, widening Novo’s early edge over Eli Lilly in the latest battleground for weight loss medicines.
A 2011 gallery paired 12 flu vaccine fears with CDC answers. Here are 10 of those myths and what the agency said.
